{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_015376.3:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_015376.3",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant in LRRK2 associated with Parkinson's disease"
        },
        {
          "HGVS": "NM_015376.3:c.4322G>C",
          "cDNA Change": {
            "transcript": "NM_015376.3",
            "ref": "G",
            "alt": "C",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "1441"
          },
          "Description in input context": "R1441C variant in LRRK2 associated with Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005157"
  },
  "Experiment Method": [
    {
      "Assay Method": "Case-control study",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Blood samples",
        "Description": "Genotyping was performed on blood samples from Parkinson's disease patients and healthy controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_015376.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S variant was significantly associated with increased risk of Parkinson's disease (p < 0.001)."
        },
        {
          "Variant": "NM_015376.3:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The R1441C variant showed a 2.3-fold increased risk for Parkinson's disease compared to controls (OR = 2.3, 95% CI 1.8-3.0)."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Replicated in three independent cohorts (n=1500 patients, n=3000 controls)."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 alleles were used as positive controls in genotype validation."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-carriers of LRRK2 variants were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Logistic regression and chi-square tests were used for association analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "OR ≤ 1.2 (p ≥ 0.05) for association with Parkinson's disease",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "OR ≥ 1.5 (p < 0.05) for association with Parkinson's disease",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Bioinformatics analysis",
      "Material used": {
        "Material Source": "Computational models",
        "Material Name": "LRRK2 protein structure",
        "Description": "In silico analysis of LRRK2 variants using computational models of the protein."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_015376.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S variant was predicted to destabilize the LRRK2 kinase domain, increasing kinase activity."
        },
        {
          "Variant": "NM_015376.3:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The R1441C variant was predicted to cause misfolding in the ROC domain, leading to increased autophagy inhibition."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}